Nanosized Trojan horses created from a patient’s own immune cells have successfully treated inflammation by overcoming the body’s complex defense mechanisms, perhaps leading to broader applications for treating diseases characterized by inflammation, such as cancer and cardiovascular diseases.
An international team, led by researchers at Houston Methodist Research Institute, described the creation of nanoparticles called leukosomes and evaluated their ability to treat localized inflammation in the May 23 issue of Nature Materials (early online).
Recent approaches to treating inflammatory diseases have been unsuccessful because an already overactive immune system treats simple nanoparticles as foreign invaders and clears them from the body, preventing them from reaching their target.
“A better approach for building effective drug delivery platforms is to find inspiration for their design in the composition of the immune cells of our body,” said Ennio Tasciotti, Ph.D., director of the Center for Biomimetic Medicine at Houston Methodist Research Institute and the paper’s senior author. “Immune cells such as leukocytes freely circulate in blood vessels, recognize inflammation, and accumulate in inflamed tissues. They do so by using special receptors and ligands on their surface. We purified leukocytes from a patient, then integrated their special ligands and receptors into the leukosome surface. Using the body’s own materials, we built a drug delivery system camouflaged as our own body’s defense system—thus the Trojan horse.”
In its normal form, acute inflammation is a necessary and beneficial part of the body’s defense against infection. However, under certain conditions, inflammation can turn from a friend to a vicious foe, damaging or destroying healthy cells. This is the case for autoimmune disorders such as rheumatoid arthritis, lupus and inflammatory bowel disease, or in illnesses such as Alzheimer’s, cancer, cardiovascular disease and Type 2 diabetes.
Leukosomes are able to target inflamed tissues because they retain the same surface properties of the immune cell membranes from which they are made. To evaluate leukosomes’ effectiveness as drug carriers, Tasciotti and his colleagues created vesicles from mouse leukocytes and filled them with dexamethasone (DXM), an anti-inflammatory agent.
“We used ‘personalized’ DXM-loaded leukosomes to treat inflammation in mice,” Tasciotti said. “After administering the leukosomes, we observed their attachment to the surface of blood vessels surrounding the inflamed tissue, and they selectively delivered DXM to the affected cells.”
The treated mice showed definite signs of improvement, including resolution of the inflammation, a significant reduction in tissue thickness, and a reversal of the immune response that is commonly seen in inflammation.
The success of the team’s initial leukosome trial is encouraging, Tasciotti said, and suggests that membranes purified from any other cell types could also be used as biomimetic nanocarriers to treat other diseases.
“By combining cell biology with nanotechnology, we can create valuable medical tools that work within, and not around, the laws of nature,” he said.
Learn more: Nanoscale trojan horses treat inflammation
The Latest on: Treating inflammation
[google_news title=”” keyword=”treating inflammation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Treating inflammation
- Potential new treatment path for lasting Lyme disease symptomson April 26, 2024 at 8:26 am
Researchers have identified a potential new treatment for persistent neurological symptoms of Lyme disease, commonly seen even after antibiotic use. The study found that fibroblast growth factor ...
- Ibogaine By David Dardashti Begins Inflammation Tests to Demonstrate Adequate Resultson April 26, 2024 at 6:55 am
Ibogaine By David Dardashti has launched a comprehensive in-clinic testing program to gauge the effects of ibogaine on the body’s inflammatory levels, and emphasizes the need for a comprehensive ...
- Anti-Inflammatory Use May Reduce PD Risk in Patients With Autoimmune Diseaseson April 26, 2024 at 6:33 am
Researchers examined the relationship between exposure to anti-inflammatory therapy and the incidence of Parkinson disease in patients with autoimmune conditions.
- Nail Psoriasis: Causes, Symptoms, and How to Treat Iton April 26, 2024 at 6:00 am
Nail psoriasis is a little-discussed aspect of the common skin condition. Dermatologists explain the causes, symptoms, and treatments of nail psoriasis.
- Better Scans Spot Hidden Inflammation in MS Patientson April 26, 2024 at 4:48 am
The PET scans revealed smoldering inflammation that lingers in the brains of MS patients, driving disease progression even though it can’t be detected on an MRI. Further, the damage to patients’ ...
- Cinnamon, curcumin, and resveratrol show promise in diabetes inflammation fighton April 25, 2024 at 11:18 pm
Researchers reviewed the impact of cinnamon, curcumin, and resveratrol on oxidative stress and inflammation in type 2 diabetes patients, highlighting their potential to improve metabolic regulation ...
- Medical Moment: The accidental discovery to treat inflammatory bowel diseaseon April 25, 2024 at 6:49 pm
There’s new hope after that same brain enzyme was found in the gut during IBD flareups, opening the door to tackle neuro and gut disease through a simple pill.
- Fecal Transplant Shows Promise for Easing Inflammatory Bowel Disease Symptomson April 25, 2024 at 4:45 pm
For the study, scientists reviewed results from 15 clinical trials that tested fecal microbiota transplants (FMT) — when stool with healthy microorganisms is inserted into a sick patient’s digestive ...
- Understanding the cellular mechanisms of obesity-induced inflammation and metabolic dysfunctionon April 25, 2024 at 6:27 am
A South Korean team has spearheaded a research endeavor that successfully uncovered the mechanisms governing inflammation and metabolic dysfunction in tissues associated with obesity. Their findings ...
- Ted Danson Has Lived With Psoriasis for 50 Years—Here Are the Dermatologist-Approved Ways He Combats Chronic Inflammationon April 24, 2024 at 12:45 pm
Actor Ted Danson and dermatologist Jennifer Soung shared the importance of seeking care for conditions like plaque psoriasis, plus some of the best ways to complement treatment.
via Bing News